AMGN vs XCUR · P/E 24, rev $10.05B vs $13.7M cap
Amgen Inc (AMGN) versus Exicure Inc (XCUR) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Exicure Inc (XCUR) is a biotechnology company listed on NASDAQ.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported XCUR revenue for 2026-06-30 was $0. Net income was -$1.1M. XCUR currently screens at market cap $13.7M.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. XCUR currently screens at market cap $13.7M.
Not investment advice. Open the AMGN and XCUR stock pages for the full models.
Not investment advice.